Its considered an investigational compound in many places and is not universally approved for medical use, but it remains under research for weight-management applications
Appetite and food intake patterns often return toward baseline levels within weeks after stopping treatment
She reports consultancy fees from AstraZeneca, Boehringer Ingelheim, Bayer, Eli Lilly, Novo Nordisk, Travere Therapeutics Inc, ProKidney and Alnylam
This is the Continual-G advantage.
They can assess your health, discuss your weight management goals, and determine if a weight loss injection might be a suitable option
In this regard, the article by Maida et al